Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp clinical trials

Explore recruiting erythropoietic protoporphyria epp or x linked protoporphyria xlp clinical trials.

Recruiting erythropoietic protoporphyria epp or x linked protoporphyria xlp studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

MT-7117-A-302 Study: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Spain, Bulgaria, Netherlands, France, Czechia, Poland +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Germany, Ireland, Spain, France, Norway, Netherlands +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

HELIOS: An Open-Label, Long-Term Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP).

Italy, France, Ireland, Belgium, Sweden, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicenter, Open-label, Long-term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

Norway, Sweden, Italy, Spain, Germany, Bulgaria +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp trials by city

Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Toronto Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Vancouver Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Montreal Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Calgary Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Edmonton Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Ottawa Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Winnipeg Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Quebec City Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Hamilton Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Kitchener Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in London Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Halifax Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in New York Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Los Angeles Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Chicago Erythropoietic Protoporphyria Epp Or X Linked Protoporphyria Xlp in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease